Astria Therapeutics, Inc.
ATXS
$5.75
$0.152.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.09M | 2.32M | 2.05M | 1.89M | 2.24M |
| Change in Net Operating Assets | -3.40M | 5.94M | -5.48M | 5.49M | -1.41M |
| Cash from Operations | -34.02M | -17.36M | -27.97M | -16.79M | -19.09M |
| Capital Expenditure | -- | 0.00 | -20.00K | -305.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.58M | -3.72M | 6.21M | -67.80M | -126.23M |
| Cash from Investing | 28.58M | -3.72M | 6.19M | -68.10M | -126.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 15.30M | 94.00K | 141.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 15.30M | 94.00K | 141.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.44M | -21.08M | -6.48M | -84.80M | -3.52M |